dihydroxyphenylalanine has been researched along with Anxiety in 10 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
Excerpt | Relevance | Reference |
---|---|---|
"Fatigue, confusion, and depression were measured on the Profile of Mood States, while barometric pressure and the ANS indices of heart rate and body temperature were also recorded." | 1.26 | Alertness and clear thinking as characteristics of high naturally occurring autonomic nervous system arousal. ( Schubert, DS, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehgoetz Martens, KA | 2 |
Ellard, CG | 2 |
Almeida, QJ | 2 |
Lefaivre, SC | 1 |
Beck, EN | 1 |
Chow, R | 1 |
Pieruccini-Faria, F | 1 |
Nifontova, LA | 1 |
Schubert, DS | 1 |
Horvath, TB | 1 |
Meares, RA | 1 |
Eisenring, JJ | 1 |
Dick, P | 1 |
Tissot, R | 1 |
Yanniotis, G | 1 |
Maskin, MB | 1 |
Riklan, M | 1 |
Chabot, D | 1 |
Barbieri, NF | 1 |
Megna, GF | 1 |
Micalizzi, V | 1 |
Pigneri, MT | 1 |
Puca, FM | 1 |
Damãsio, AR | 1 |
Lobo-Antunes, J | 1 |
Macedo, C | 1 |
Celesia, GG | 1 |
Barr, AN | 1 |
1 trial available for dihydroxyphenylalanine and Anxiety
Article | Year |
---|---|
Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.
Topics: Aged; Anxiety; Biomechanical Phenomena; Case-Control Studies; Dihydroxyphenylalanine; Dopamine Agent | 2015 |
9 other studies available for dihydroxyphenylalanine and Anxiety
Article | Year |
---|---|
Anxiety provokes balance deficits that are selectively dopa-responsive in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Anxiety; Dihydroxyphenylalanine; Female; Humans; Male; Parkinson Disease | 2017 |
[Increased predisposition to syncope in vasovagal syncope].
Topics: Adult; Anxiety; Blood Vessels; Cardiovascular Diseases; Corticosterone; Dihydroxyphenylalanine; Epin | 1980 |
Alertness and clear thinking as characteristics of high naturally occurring autonomic nervous system arousal.
Topics: Adult; Aged; Aggression; Anxiety; Arousal; Atmospheric Pressure; Autonomic Nervous System; Body Temp | 1977 |
The relevance of the neurophysiological concepts of excitation and inhibition to clinical psychiatry.
Topics: Acoustic Stimulation; Adolescent; Adult; Aged; Alcohol Amnestic Disorder; Anxiety; Arousal; Dihydrox | 1973 |
[Combination of L-dopa, desipramine, and a decarboxylase inhibitor in the treatment of depression (author's transl)].
Topics: Adult; Aged; Anxiety; Carbidopa; Carboxy-Lyases; Depression; Desipramine; Dihydroxyphenylalanine; Dr | 1973 |
A preliminary study of selected emotional changes in Parkinsonians on L-dopa therapy.
Topics: Anxiety; Depression; Dihydroxyphenylalanine; Emotions; Hostility; Humans; Middle Aged; Paranoid Diso | 1972 |
[Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
Topics: Amantadine; Anxiety; Depression; Dihydroxyphenylalanine; Emotions; Humans; Intelligence Tests; Menta | 1971 |
Psychiatric aspects in Parkinsonism treated with L-dopa.
Topics: Affect; Aged; Antidepressive Agents; Anxiety; Arousal; Barbiturates; Cognition Disorders; Depression | 1971 |
Psychosis and other psychiatric manifestations of levodopa therapy.
Topics: Adult; Aged; Anxiety; Depression; Dihydroxyphenylalanine; Euphoria; Female; Humans; Male; Middle Age | 1970 |